Navigation Links
Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor

ST. LOUIS, Aug. 13 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) announced today that its chemistry review journal, Aldrichimica Acta, was recently ranked number one by Impact Factor (IF) when evaluated against all 55 international journals in the field of Organic Chemistry.

"We are excited about this latest ranking of the Acta by such a prestigious organization as Thomson Reuters," said Dr. Sharbil Firsan, Editor of the Aldrichimica Acta. "We are especially thrilled by the significant one-year jump in Impact Factor from 2007 to 2008, a clear confirmation of the high esteem in which our fellow chemists hold the Acta, and a testament of its continued value to the research community. It is no coincidence that some of the most prominent names in chemistry have published in the Acta over the past 42 years, including six Nobel laureates. These rankings will continue to inspire Sigma-Aldrich to make the Acta even more valuable to scientists and technologists around the world."

While the Aldrichimica Acta has been ranked number one by Impact Factor for seven of the past eight years, this latest IF ranking (2008) is based on an Impact Factor of 16.733--a jump of more than 4 points over the Acta's 2007 IF score of 11.929. In 2008, the Acta was also ranked first by Five-Year Impact Factor and by Article Influence(TM) Score, a measure of the relative importance of the journal on a per-article basis. These rankings appear annually in the Science Edition of Journal Citation Reports(R), which tracks over 6,500 international science journals annually and offers quantifiable statistical data that enables the systematic ranking of journals by relative importance within their subject categories.

The Aldrichimica Acta publishes in-depth reviews on topics of current interest to chemists up to four times a year, and is distributed at no charge to more than 120,000 subscribers worldwide. To subscribe to the Acta or to access back issues (from 1968), please go to For a CD-ROM of back issues, please visit

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 38 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at

* Journal Citation Reports is a registered trademark and Article Influence(TM) Score a trademark of Thomson Reuters. Sigma-Aldrich is a registered trademark of Sigma-Aldrich L.P. and Sigma-Aldrich Co.

SOURCE Sigma-Aldrich
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
2. Digital Healthcare Specialist Cadient Group Ranked #2 on List of Full-service Advertising Agencies in the Philadelphia Region
3. Genoptix Ranked Ninth Fastest-Growing Company in North America on Deloittes 2008 Technology Fast 500
4. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
5. Abt Associates Ranked One of Top 20 U.S. Market Research Firms
6. Alma Lasers Ranked 9th in Deloitte Technology Fast 50 Award
7. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
8. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
9. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
10. First Pediatric Patient Treated With Aptocine(TM), a Novel Light-Activated Drug, in Neurofibromatosis Study
11. Jennerex Closes $5 Million First Tranche of Series C Financing
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... metabolism. But unless it is bound to proteins, copper is also toxic to ... researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of copper ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ - ... the request of IIROC on behalf of the Toronto ... this news release there are no corporate developments that ... price. --> --> ... --> . --> Aeterna Zentaris ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... ... , ... The Academy of Model Aeronautics (AMA), led by its Executive Council, ... Grand Prix, to represent the First–Person View (FPV) racing community. , FPV racing has ... type of racing and several new model aviation pilots have joined the community because ...
Breaking Biology Technology:
(Date:10/27/2015)... -- Munich, Germany , October ... automatically maps data from mobile eye tracking videos created ... that they can be quantitatively analyzed with SMI,s analysis ... , October 28-29, 2015. SMI,s Automated Semantic Gaze ... tracking videos created with SMI,s Eye Tracking Glasses ...
(Date:10/26/2015)...  Delta ID Inc., a company focused on bringing ... devices, announced its ActiveIRIS® technology powers the iris recognition ... by NTT DOCOMO, INC in Japan ... to include iris recognition technology, after a very successful ... May 2015, world,s first smartphone to have this capability. ...
(Date:10/22/2015)... SYNA ), a leading developer of human interface solutions, today reported ... --> --> Net revenue for ... comparable quarter last year to $470.0 million. Net income for the ... diluted share. --> --> ... 39 percent over the prior year period to $56.9 million, or ...
Breaking Biology News(10 mins):